Clinical Observation Efficacy of External Counterpulsation Combined with Yixin Decoction in Patients with Coronary Heart Disease Complicated with Cardiac Dysfunction of Qi Deficiency and Blood Stasis

Abstract

Abstract: Objective To observe the clinical effect of external counterpulsation combined with traditional Chinese medicine decoction Yixin Decoction on coronary heart disease patients with qi deficiency and blood stasis type combined with cardiac insufficiency. Methods Selected 50 patients who met the inclusion criteria from January 2021 to January 2022 in the Department of Cardiovascular Medicine, Tianshan Hospital of Traditional Chinese Medicine, Changning District. They were randomly divided into an observation group (25 cases, receiving external counterpulsation + Yixin Decoction + conventional drug treatment) and a control group (25 cases, receiving Yixin Decoction + conventional drug treatment), The TCM symptom scores, cardiac function, 6-minute walking distance (6MWD), serum brain natriuretic peptide (BNP) and other changes were observed before and after treatment in the two groups of patients. Results Patients in the observation and control groups had lower TCM evidence scores and serum BNP after treatment, cardiac ejection fraction and 6-minute walking distance were higher than those before treatment (P<0.05). After treatment, the symptom scores of chest tightness and palpitation in observation group were reduced compared with control group, and the 6-minute walking distance,cardiac ejection fraction were improved compared with control group (P<0.05). Conclusion The combination of external counterpulsation with traditional Chinese medicine decoction Yixin Tang and conventional Western medicine treatment has a positive therapeutic effect on the six minute walking distance, BNP, and LVEF of patients with Qi deficiency and blood stasis type coronary heart disease combined with cardiac insufficiency compared to a simple Western medicine treatment plan. At the same time, it improves the clinical syndrome score of traditional Chinese medicine and benefits patients more in terms of quality of life.

Key words: external counterpulsation, Yixin decoction, coronary heart disease, qi deficiency and blood stasis, cardiac insufficiency

CLC Number:

R256.2

ZHAO Yu-hong, TIAN Jun, NING Si-si, CUI Zhao-qiang, YAN Lei, SHI Jia-wei, YUAN Yuan. Clinical Observation Efficacy of External Counterpulsation Combined with Yixin Decoction in Patients with Coronary Heart Disease Complicated with Cardiac Dysfunction of Qi Deficiency and Blood Stasis[J]. ZHONGHUA YANGSHENG BAOJIAN, 2024, 42(1): 1-4.

References

[1] World Health Organization.Global health estimates: leading causes of death[EB/OL].[2023-06-25].https://www.who.int/data/gho/data/themes/mortality-and-global-health-estimates/ghe-leading-causes-of-death.
[2] LOH P H, CLELAND J G F, LOUIS A A, et al. Enhanced external counterpulsation in the treatment of chronic refractory angina: a long-term follow-up outcome from the International Enhanced External Counterpulsation Patient Registry[J]. Clin Cardiol,2008,31(4):159-164.
[3] CHENG K, DE SILVA R.New Advances in the management of refractory angina pectoris[J]. Eur Cardiol,2018,13(1):70-79.
[4] NICHOLS W W, ESTRADA J C, BRAITH R W, et al.Enhanced external counterpulsation treatment improves arterial wall properties and wave reflection characteristics in patients with refractory angina[J]. J Am Coll Cardiol,2006,48(6):1208-1214.
[5] 国家中医药管理局.中药新药临床研究指导原则[M].北京:中国医药科技出版社,2002:69.
[6] 张辉,赵东升,王云豹.增强型体外反搏通过调节endocan-1和vaspin水平改善血管内皮功能障碍[J].中国动脉硬化杂志,2022,30(2):141-146.
[7] 李媛媛,赵娅,倪烨,等.增强型体外反搏对冠心病患者白细胞介素-1白细胞介素-6肿瘤坏死因子-α水平的影响[J].山西医药杂志,2021,50(23):3273-3275.
[8] 刘洪,宫丽鸿.稳斑汤联合增强型体外反搏干预冠心病PCI术后的疗效及对血清SOD、MDA的影响[J].中西医结合心脑血管病杂志,2020,18(5):789-791.
[9] MELIN M, MONTELIUS A, RYDÉN L, et al. Effects of enhanced external counterpulsation on skeletal muscle gene expression in patients with severe heart failure[J]. Clin Physiol Funct Imaging,2018,38(1):118-127.
[10] 章轶立,李园,刘俊杰,等.基于生物分子网络的黄芪-丹参药对干预慢性心力衰竭作用机制预测研究[J].中国中医药信息杂志,2020,33(9):74-75.
[11] 王涵,林红强,谭静,等.党参药理作用及临床应用研究进展[J].世界最新医学信息文摘,2019,19(7):27-28,30.
[12] 戴璐璐,陈可冀,蒋跃绒,等.基于数据挖掘探析活血化瘀类中成药治疗心脑血管病的组方规律[J].中国中西医结合杂志,2022,42(3):311-316.
[13] 苑婕,贺虹,张维金.基于随机森林算法的赤芍成分-靶点-心脑血管疾病网络药理作用研究[J].中国新药杂志,2019,24(11):1391-1396.
[14] 孙振海,张芮,石英宁,等.基于数据挖掘和网络药理学探析中医药治疗冠心病作用机制[J].辽宁中医药大学学报,2021,23(12):76-82.